0Y7T Allergan Plc

 
TIDMIRSH 
 
Ap19 
 
                                                                       FORM 8.3 
 
                             IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER 
                                  RULES, 2013 
 
 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR 
                                     MORE 
 
 1. KEY INFORMATION 
 
Name of person dealing (Note Pentwater Capital Management 
1)                           LP 
 
Company dealt in              Allergan Plc 
 
Class of relevant security   $0.0001 Ordinary Shares 
to which the dealings being 
disclosed relate (Note 2) 
 
Date of dealing               May 07, 2020 
 
        2.  INTERESTS AND SHORT POSITIONS 
 
 a. Interests and short positions (following dealing) in the class of relevant 
    security dealt in (Note 3) 
 
                                     Long         Short 
 
                             Number        (%)    Number      (%) 
 
(1) Relevant securities        1,732,042 
                             0.53% 
 
(2) Derivatives (other than    6,228,649 
options)                     1.89% 
 
(3) Options and agreements                         495,000 
to purchase/sell                                     0.15% 
 
Total                          7,960,691           495,000 
                                 2.42%               0.15% 
 
 
        b.  Interests and short positions in relevant securities of the 
company, other than the class dealt in (Note 3) 
 
Class of relevant security:        Long        Short 
 
                             Number      (%)   Number      (%) 
 
(1) Relevant securities 
 
 
(2) Derivatives (other than 
options) 
 
 
(3) Options and agreements 
to purchase/sell 
 
Total 
 
 
Ap20 
 
 1. DEALINGS (Note 4) 
 
 a. Purchases and sales 
 
 
Purchase/sale   Number of relevant        Price per unit 
                securities                (Note 5) 
 
   sale                                       194.12  USD 
                10,000 
 
        b.  Derivatives transactions (other than options transactions) 
 
Product     Nature of       Number of relevant   Price per 
name,       transaction     securities           unit 
e.g. CFD    (Note 6)        (Note 7)             (Note 5) 
 
 
        c.  Options transactions in respect of existing relevant securities 
 
 i. Writing, selling, purchasing or varying 
 
Product   Writing,    Number of   Exercise Type,     Expiry Option 
name,     selling,    securities  price    e.g.      date   money 
e.g. call purchasing, to which             American,        paid/ 
option    varying     the option           European         received 
          etc.        relates              etc.             per unit 
                      (Note 7)                              (Note 5) 
 
 
        ii.  Exercising 
 
Product name,   Number of securities      Exercise price 
e.g. call                                 per unit (Note 
option                                    5) 
 
 
 
        d.  Other dealings (including transactions in respect of new 
securities) (Note 4) 
 
Nature of       Details                   Price per unit 
transaction                               (if applicable) 
(Note 8)                                  (Note 5) 
 
 
                                                                           Ap21 
 
        2.  OTHER INFORMATION 
 
Agreements, arrangements or understandings relating to options or derivatives 
 
Full details of any agreement, arrangement or understanding between the person 
disclosing and any other person relating to the voting rights of any relevant 
securities under any option referred to on this form or relating to the voting 
rights or future acquisition or disposal of any relevant securities to which 
any derivative referred to on this form is referenced. If none, this should be 
stated. 
 
Is a Supplemental Form 8 attached? (Note 9) 
                                            YES 
 
Date of disclosure               May 8, 2020 
 
Contact name                     Neal Nenadovic 
 
Telephone number                 312-589-6405 
 
If a connected EFM, name of 
offeree/offeror with which 
connected 
 
If a connected EFM, state 
nature of connection (Note 
10) 
 
 
 
 
 
                               SUPPLEMENTAL FORM 8 
 
                              IRISH TAKEOVER PANEL 
 
 DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,   1997, 
                        TAKEOVER RULES, 2007 (AS AMENDED) 
 
                            DETAILS OF OPEN POSITIONS 
 
  (This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 
                             8.3, as   appropriate) 
 
 
 
                             OPEN POSITIONS (Note 1) 
 
Product     Written or    Number of         Exercise    Type, e.g.    Expiry date 
name, e.g.  purchased     relevant          price (Note American, 
call option               securities to     2)          European etc. 
                          which the option 
                          or derivative 
                          relates 
 
Put option  Purchased             (300,000) 150.00 USD      American  06/19/20 
 
Put option  Purchased                       155.00 USD     American   06/19/20 
                          (125,000) 
 
Put option  Purchased                       145.00 USD      American  06/19/20 
                          (70,000) 
 
 
 
END 
 

(END) Dow Jones Newswires

May 11, 2020 02:00 ET (06:00 GMT)

Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025

Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025